BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23009585)

  • 1. Availability of yttrium-90 from strontium-90: a nuclear medicine perspective.
    Chakravarty R; Dash A; Pillai MR
    Cancer Biother Radiopharm; 2012 Dec; 27(10):621-41. PubMed ID: 23009585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid determination of (90)Sr impurities in freshly "generator eluted"(90)Y for radiopharmaceutical preparation.
    Bonardi ML; Martano L; Groppi F; Chinol M
    Appl Radiat Isot; 2009 Oct; 67(10):1874-7. PubMed ID: 19628401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yttrium-90 -- current status, expected availability and applications of a high beta energy emitter.
    Montaña RL; González IH; Ramirez AA; Garaboldi L; Chinol M
    Curr Radiopharm; 2012 Jul; 5(3):253-63. PubMed ID: 22697484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an electrochemical 90 Sr-90 Y generator for separation of 90 Y suitable for targeted therapy.
    Chakravarty R; Pandey U; Manolkar RB; Dash A; Venkatesh M; Pillai MR
    Nucl Med Biol; 2008 Feb; 35(2):245-53. PubMed ID: 18312836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
    Pillai MR; Dash A; Knapp FF
    Curr Radiopharm; 2012 Jul; 5(3):228-43. PubMed ID: 22642385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitation functions of (alpha,xn) reactions on (nat)Rb and (nat)Sr from threshold up to 26 MeV: possibility of production of (87)Y, (88)Y and (89)Zr.
    Kandil SA; Spahn I; Scholten B; Saleh ZA; Saad SM; Coenen HH; Qaim SM
    Appl Radiat Isot; 2007 May; 65(5):561-8. PubMed ID: 17344051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile radiochemical separation of clinical-grade
    Chakravarty R; Chakraborty S; Jadhav S; Dash A
    Nucl Med Biol; 2019; 68-69():58-65. PubMed ID: 30770227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale purification of 90Sr from nuclear waste materials for production of 90Y, a therapeutic medical radioisotope.
    Wester DW; Steele RT; Rinehart DE; DesChane JR; Carson KJ; Rapko BM; Tenforde TS
    Appl Radiat Isot; 2003 Jul; 59(1):35-41. PubMed ID: 12878120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and separation of no-carrier-added radioactive tracers of yttrium, strontium and rubidium from heavy-ion irradiated germanium target: applicability to the standardization of a separation technique for production of positron-emitting radionuclide 86Y.
    Pal S; Chattopadhyay S; Das MK; Sudersanan M
    Appl Radiat Isot; 2006 Dec; 64(12):1521-7. PubMed ID: 16822676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and purification of therapeutic dose of
    Chakravarty R; Chakraborty S; Dash A
    Appl Radiat Isot; 2017 Mar; 121():1-5. PubMed ID: 28012419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of carrier added and no carrier added 90Y-EDTMP as bone seeking therapeutic radiopharmaceutical.
    Khalid M; Bokhari TH; Ahmad M; Bhatti HN; Iqbal M; Ghaffar A; Qadir MI
    Pak J Pharm Sci; 2014 Jul; 27(4):813-8. PubMed ID: 25015445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study for the production of high specific activity radionuclides for nuclear medicine obtained with the isotope separation on line technique.
    Borgna F; Ballan M; Corradetti S; Vettorato E; Monetti A; Rossignoli M; Manzolaro M; Scarpa D; Mazzi U; Realdon N; Andrighetto A
    Appl Radiat Isot; 2017 Sep; 127():214-226. PubMed ID: 28649019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90Sr content in 90Y-labeled SIR-spheres and Zevalin.
    Metyko J; Erwin W; Poston J; Jimenez S
    Health Phys; 2014 Nov; 107(5 Suppl 3):S177-80. PubMed ID: 25272027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 86Y based PET radiopharmaceuticals: radiochemistry and biological applications.
    Nayak TK; Brechbiel MW
    Med Chem; 2011 Sep; 7(5):380-8. PubMed ID: 21711222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
    Jeong JM; Knapp FF
    Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic separation of carrier free 90Y from 90Sr using a diglycolamide based resin for possible pharmaceutical applications.
    Dutta S; Mohapatra PK; Raut DR; Manchanda VK
    J Chromatogr A; 2011 Sep; 1218(37):6483-8. PubMed ID: 21835417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic Imaging of Yttrium-90.
    Wright CL; Zhang J; Tweedle MF; Knopp MV; Hall NC
    Biomed Res Int; 2015; 2015():481279. PubMed ID: 26106608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of large quantities of 90Y by ion-exchange chromatography using an organic resin and a chelating agent.
    Castillo AX; Pérez-Malo M; Isaac-Olivé K; Mukhallalati H; González EC; Berdeguez MT; Díaz NC
    Nucl Med Biol; 2010 Nov; 37(8):935-42. PubMed ID: 21055624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production of [124I]iodine and [86Y]yttrium.
    Schmitz J
    Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1():S4-9. PubMed ID: 21484376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach for preferential recovery of Sr from (Sr, Th)O2.
    Vyas CK; Joshirao PM; Shukla R; Tyagi AK; Manchanda VK
    J Hazard Mater; 2012 Nov; 241-242():340-7. PubMed ID: 23084243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.